Thought Leadership and Researched Editorial
The company has created new products and procedures to help with chronic pain management, period pain and diabetes-related conditions. It has also expanded into the veterinary space with new non-invasive pain and lameness solutions in equine health.
The company’s funding to date – and revenue – has helped it forge relationships with partners, clinicians, and go-to-market resellers. However, in order to build on the success of the company’s MVP it is seeking additional investment outside its angel network of investors-to-date.